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Abstract
Background: The fetal cortical neuroepithelium is a mosaic of distinct progenitor populations that
elaborate diverse cellular fates. Ethanol induces apoptosis and interferes with the survival of
differentiating neurons. However, we know little about ethanol's effects on neuronal progenitors.
We therefore exposed neurosphere cultures from fetal rat cerebral cortex, to varying ethanol
concentrations, to examine the impact of ethanol on stem cell fate.
Results: Ethanol promoted cell cycle progression, increased neurosphere number and increased
diversity in neurosphere size, without inducing apoptosis. Unlike controls, dissociated cortical
progenitors exposed to ethanol exhibited morphological evidence for asymmetric cell division, and
cells derived from ethanol pre-treated neurospheres exhibited decreased proliferation capacity.
Ethanol significantly reduced the numbers of cells expressing the stem cell markers CD117,
CD133, Sca-1 and ABCG2, without decreasing nestin expression. Furthermore, ethanol-induced
neurosphere proliferation was not accompanied by a commensurate increase in telomerase
activity. Finally, cells derived from ethanol-pretreated neurospheres exhibited decreased
differentiation in response to retinoic acid.
Conclusion: The reduction in stem cell number along with a transient ethanol-driven increase in
cell proliferation, suggests that ethanol promotes stem to blast cell maturation, ultimately depleting
the reserve proliferation capacity of neuroepithelial cells. However, the lack of a concomitant
change in telomerase activity suggests that neuroepithelial maturation is accompanied by an
increased potential for genomic instability. Finally, the cellular phenotype that emerges from
ethanol pre-treated, stem cell depleted neurospheres is refractory to additional differentiation
stimuli, suggesting that ethanol exposure ablates or delays subsequent neuronal differentiation.
Published: 13 September 2005
BMC Neuroscience 2005, 6:59 doi:10.1186/1471-2202-6-59
Received: 01 July 2005
Accepted: 13 September 2005
This article is available from: http://www.biomedcentral.com/1471-2202/6/59
© 2005 Santillano et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 17
(page number not for citation purposes)
BMC Neuroscience 2005, 6:59 http://www.biomedcentral.com/1471-2202/6/59Background
Children exposed to alcohol during gestation can exhibit
a spectrum of abnormalities that range from Alcohol
Related Neurodevelopmental Disorders (ARND) to Fetal
Alcohol Syndrome (FAS), based upon the severity of
symptoms. These abnormalities can include facial anom-
alies, growth deficits, mental retardation, attention defi-
cit/hyperactivity disorders, motor difficulties, learning
and memory impairment and psychological disorders
such as depression [1-9]. Ethanol is teratogenic and exerts
pleiotrophic effects in the differentiating nervous system,
including induction of cell-death mechanisms [10-13],
disruption of trophic support [14-17] and deregulation of
neurotransmitter networks like the GABA, glutamate and
serotonergic systems [18-24].
During prenatal period of neurogenesis, the number of
neuroepithelial cells expands rapidly to generate most of
the neurons of the adult brain [25] requiring, as with
other tissues [26], the conversion of un-committed stem
cells to more fate-restricted neuroblasts, and ultimately
neurons. Ethanol exposure during gestation may alter the
number and types of neuronal stem and blast precursors
available for normal development, potentially producing
irreversible damage to the developing brain. For example,
previous research using BrdU incorporation analyses has
shown that ethanol suppresses cell-cycle in the ventricular
zone while promoting proliferation in the more mature
subventricular zone [27]. The opposing effect of ethanol
on these two cell populations indicates that ethanol dis-
rupts the normal balance of precursor populations and
suggests that ethanol may not affect all immature precur-
sors similarly. We know little about the molecular hetero-
geneity of cortical neuroepithelial cells, though emerging
evidence suggests that the neuroepithelium is quite heter-
ogeneous with respect to differentiation and gene expres-
sion states of its constituent cells [28-30]. Cell surface
markers like CD133/prominin-1, Sca-1 (Ly6A/E),
CD117/c-kit and ABCG2 (ATP-binding cassette, sub-fam-
ily G (WHITE), member 2) have been used successfully to
monitor stem cell heterogeneity in a variety of tissues [31-
34], and we therefore used these markers to monitor neu-
ronal stem cell heterogeneity following ethanol exposure.
We hypothesized that if ethanol influenced the prolifera-
tion of neuroepithelial cells, it would also alter the num-
bers of stem cells within the cortical neuroepithelium.
Finally, mechanisms that maintain genomic stability are
important during neurogenesis because the frequency of
DNA synthesis errors and aberrant chromatin assembly
are increased during periods of robust proliferation. These
errors must be limited, so that neural stem cells do not
accumulate and transmit genetic damage to daughter
cells. The telomerase complex, a reverse transcriptase
enzyme complex, maintains telomeres during DNA repli-
cation [35-37], thereby preventing genomic instability
and cellular senescence. Telomerase is active in all germ-
line tissues, transformed cells and most human cancers
[38,39], but is particularly robust during neurogenesis
where it has been shown to function as an anti-apoptotic
factor in developing neurons [40,41]. The activation of
telomerase during neurogenesis, and the anti-apoptotic
role of telomerase in neurons, led us to hypothesize that
telomerase is a molecular target for ethanol during neu-
roblast expansion.
To examine the effects of ethanol on cortical precursor
growth and survival, neurosphere cultures were generated
from gestational day 15 rat fetuses. Contrary to our initial
hypothesis, prolonged ethanol exposure promoted cell-
cycle activity without concomitant increases in telomerase
activity, or significant apoptosis. However, despite
directly increasing cell cycle activity, ethanol suppressed
expression of several stem cell markers, and decreased the
future proliferation and differentiation potential of
exposed cortical-derived neurospheres. Collectively, these
data indicate that stem cell diversity, stability, and matu-
ration are likely to be important components of the pre-
natal brain damage caused by maternal ethanol
consumption.
Results
Neuronal progenitor cells, including multi-potent stem,
and more committed blast cells, can be isolated from the
developing cortex, expanded in-vitro as neurosphere
aggregates, and subsequently used to generate neurons
and glia [42-44]. Acutely dissociated cortical progenitors
were cultured as neurosphere aggregates in serum-free
mitogenic media to model the period of neuroblast pre-
cursor expansion during neurogenesis in the rodent. Cul-
tured neurospheres were immuno-positive for nestin
(Figure 1A), consistent with the hypothesis that neuro-
spheres were comprised of immature cells. In contrast,
immunofluorescence for the neuronal nuclear antigen
(NeuN) was expressed within the soma of a few progeni-
tor cells at the periphery of the neurosphere, but did not
co-localize to any nucleus (Figure 1B). The presence of
nestin [45] indicates that neurospheres are immature and
multi-potent, and the lack of nuclear labeling for NeuN
(Figure 1B) indicates that these cells are not yet commit-
ted to neuronal differentiation. In contrast, differentia-
tion, induced by removal of Epidermal Growth Factor and
culturing neurosphere-derived cells on a laminin sub-
strate, leads to clear nuclear expression of NeuN (Figure
1C) and suppression of nestin immunoreactivity (data
not shown), suggesting that neurosphere-derived cells can
be committed to a neuronal lineage. Additionally, our
flow cytometric data (Figure 2) indicate that, on average,
less than 4% of cells in neurosphere cultures arePage 2 of 17
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this culture model.
Ethanol exposure activates cell cycle activity in primary 
cortical neurosphere cultures and does not lead to 
apoptosis
Figure 2A (i-iii) illustrates the proportion of cells in cell
cycle in response to ethanol treatment measured by flow
cytometry. Exposure to ethanol for 4 days induced cell
cycle activity at 120 mg/dl and 620 mg/dl, respectively.
The proportion of cells in S-phase increased significantly
(by 1.8–1.9 fold) after exposure to both doses of ethanol,
relative to controls (Figure 2Bi). Furthermore, the etha-
nol-stimulated increase in the S-phase fraction was mir-
rored by a significant increase (1.8 – 2.5 fold) in the
percentage of cells progressing to the G2 phase of the cell
cycle (Figure 2Bii). The ratio of G2/S reflects the propor-
tion of cells completing DNA synthesis and cellular divi-
sion. At low ethanol concentrations (120 mg/dl), the G2/
S ratio was similar to controls, but the ratio increased with
higher ethanol concentrations (620 mg/dl) suggesting
that the increase in DNA synthesis did result in progres-
sion to the G2 phase of the cell cycle (Figure 2Biii). Etha-
nol did not alter the number of cells with less than G0
DNA content (a marker of apoptosis, [46]), indicating
that ethanol did not induce significant apoptosis in corti-
cal-derived neurosphere cultures (Figure 2Biv).
Consistent with the above data, morphometric analyses
indicate that ethanol significantly increased the density of
neurospheres per field (Figure 3A–D). Analysis of variance
followed by post-hoc statistical analyses indicated that
ethanol induced a dose-related increase in the density of
neurospheres (p < 0.001, Figure 3E). We observed a mod-
erate but statistically significant correlation (Pearson
product moment correlation (r) of 0.52 (p < 0.001))
between ethanol dose and density of neurospheres in the
culture dish. When we controlled for the effect of neuro-
sphere size on the density of neurospheres (i.e., the fact
that an increase in the number of large neurospheres
would effectively decrease the density of neurospheres
within a field), the partial correlation coefficient between
ethanol dose and neurosphere number increased (r =
0.71, p < 0.0001). While an overall analysis of variance
indicated that ethanol did not statistically increase neuro-
sphere size (Figure 3F), ethanol did lead to a ~2-fold
increase in variation in neurosphere size at 120 mg/dl and
a ~3-fold increase at 320 mg/dl within the culture dish, as
indicated by an increase in the variance measure (i.e.,
Standard Deviation, Figure 3G). Therefore, ethanol-
Photomicrographs depicting immunofluorescence analysis of neurospheres labeled for intermediate filament proteins nestin (A), and the neuronal linea e arker, the neuronal-specific nuclear antig n, N uN (B a d lower magnification inset)Figure 1
Photomicrographs depicting immunofluorescence analysis of neurospheres labeled for intermediate filament proteins nestin 
(A), and the neuronal lineage marker, the neuronal-specific nuclear antigen, NeuN (B and lower magnification inset). Cell 
nuclei were counter-stained with DAPI (blue). Control neurosphere cultures are immuno-positive for nestin. However, cul-
tures do not exhibit nuclear localization of NeuN, showing that neurosphere cultures were comprised of immature cells. (C) 
Differentiation following removal of the mitogen EGF, and dispersion of cells onto a laminin substrate, results in the upregula-
tion and nuclear localization of NeuN. Photomicrograph represents a digitally merged immunofluorescence and phase contrast 
microscopic image showing NeuN immunofluorescence overlying nuclei (white arrows) of early differentiating neurons. Scale 
bars: 50 uM.
Nestin + DAPI NeuN + DAPI NeuN + Phase Contrast
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BMC Neuroscience 2005, 6:59 http://www.biomedcentral.com/1471-2202/6/59(A) Cell-cycle analysis of cortical progenitors treated with ethanol for 4 daysFigur  2
(A) Cell-cycle analysis of cortical progenitors treated with ethanol for 4 days. (Ai-iii) Flow-cytometric frequency histograms of 
progenitors stained with propidium iodide (PI) for DNA content. (Aii,iii) Ethanol stimulates DNA synthesis and cell-cycle pro-
gression, as indicated by the increase in area under the S-phase and G2/M peaks, relative to controls. Bi-iii, Quantitative analy-
ses of cell-cycle. (Bi,ii) Ethanol significantly increased the number of cells entering S and G2/M-phases of the cell-cycle. (Biii) 
The G2/S ratio was unchanged at low ethanol doses, but significantly increased with the high dose. (Biv) Ethanol did not induce 
apoptosis at either dose used, and very little DNA fragmentation was observed in the sub-G0/1 range in (Ai-iii). Asterisks indi-
cate statistical-significance, p < 0.05.
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BMC Neuroscience 2005, 6:59 http://www.biomedcentral.com/1471-2202/6/59treated cultures exhibited a high degree of variability in
neurosphere size compared to untreated cultures, and
some of the neurospheres in ethanol treated cultures were
extremely large (Figure 3C, D compared to 3A&B). It is
possible that the ethanol-associated increased size and
growth rate of neurospheres may translate into decreased
viability of stem and progenitor pools within the neuro-
sphere. However, this scenario is unlikely to be true since
the overall rate of cell death was unchanged by treatment
condition (Figure 2). Hence, these data collectively sup-
port the hypothesis that ethanol induced cell cycle in neu-
rosphere cultures. One interesting observation was that
ethanol-exposed neurospheres loose their spherical shape
and exhibit irregular edges, suggesting either a structural
disorganization of the neurosphere, perhaps due to varia-
ble growth rates within different parts of an individual
neurosphere, or alternatively, the merging together of
smaller neurospheres.
Our observation that ethanol-treated neurospheres exhib-
ited increased heterogeneity in size and assumed a disor-
ganized shape over time suggested that ethanol may
promote differential responses among cells within an
individual neurosphere. We therefore dissociated neuro-
spheres (Figure 4A), and cultured individual cells in
mitogenic medium with or without ethanol (120 mg/dl)
to determine if individual cortical precursors could regen-
erate neurospheres. Over a four-day treatment period,
control (Figure 4D) and ethanol-treated neural progeni-
tors (Figure 4B) proliferated symmetrically, to generate
morphologically similar daughter cells (symmetrical divi-
sion, Figure 4E), and ultimately to generate new neuro-
spheres over a 72-hour period (Figure 4G). Under the
mitogenic conditions used (see cell culture methods), we
only observed symmetrical cell division in control cul-
tures. However, in contrast to control cultures, ethanol-
treated neurospheres also exhibited an asymmetric mode
of division, where one daughter cell assumed a more dif-
ferentiated morphology compared to its mitotic partner
(Figure 4C). One of the asymmetrically dividing pair of
cells tended to be non-motile, while the second daughter
cell exhibited extensive somatic motility (Figure 4F, H)
over a period of 72 hours. In a majority of cases, the more
morphologically differentiated member of the asymmetri-
cally dividing pair assumed a stellate morphology. Occa-
sionally, one of the pair of asymmetrically dividing
Ethanol increases neurosphere number and increases variation in the size of neurospheresFigure 3
Ethanol increases neurosphere number and increases variation in the size of neurospheres. (A-D) Representative photomicro-
graphs of control (A,B) and ethanol-treated (C,D) neurospheres showing that ethanol (at 5 days exposure) increases both the 
density and size variation of neurospheres. Arrows mark the appearance of large neurospheres in ethanol-treated cultures. (E-
G) Morphometric analyses show that ethanol induces a significant increase in the density of neurospheres (E), without altering 
the mean area per neurosphere (in square pixels, F). However, ethanol induced a dose-related increase in variation (Standard 
Deviation) in neurosphere size (G). Asterisks indicate statistical-significance, p < 0.05. Scale bar: A-D, 100 uM.
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BMC Neuroscience 2005, 6:59 http://www.biomedcentral.com/1471-2202/6/59daughter cells transiently expressed elongated, radial-glia-
like processes (e.g., Figure 4F), before assuming a stellate
appearance, despite the continued presence of mitogenic
medium.
The presence of asymmetric cell division events in etha-
nol-treated cultures suggested that ethanol forces progen-
itor cell maturation, potentially depleting the numbers of
self-replicating progenitors in neurosphere cultures.
Therefore, we next determined the extent to which etha-
nol altered the future proliferation capacity of neural pro-
genitor cells. We treated neurospheres with ethanol for
four days; then dissociated the neurospheres into single
cells that were cultured in mitogenic medium for two
days. Prior exposure to ethanol led to a statistically signif-
icant (p < 0.0001, Figure 5) dose-related decline in the
numbers of clonal colonies that were formed from disso-
ciated cells, suggesting that a prior episode of ethanol ulti-
mately depletes the proliferative capacity of cortical
progenitors.
Ethanol suppresses cell-surface stem cell marker 
expression but not nestin mRNA expression in 
neurospheres
Neurosphere cultures consist of a heterogeneous mixture
of immature neuronal stem cells and more differentiated
daughter neuroblasts [47]. Based on our observations that
ethanol promoted cell cycle activity, we hypothesized that
ethanol would also lead to an aberrant expansion of the
stem cell pool in neurosphere cultures. In the initial set of
experiments, we utilized flow-cytometry to examine the
expression of three stem cell markers, Sca-1 (Ly6A/E),
CD117/c-kit and CD133/prominin-1. Figure 6 shows that
these stem cell antigens are expressed in vitro in control
proliferating neurosphere cultures. However, contrary to
our hypothesis, we observed a large and statistically
Ethanol induces asymmetric division of neural progenitor cellsFigure 4
Ethanol induces asymmetric division of neural progenitor cells. Dissociated neural progenitor cells (A) cultured under 
mitogenic conditions divide symmetrically to generate two similar daughter cells (D, representative examples of cells undergo-
ing cytokinesis), and regenerate new neurospheres (data not shown). Ethanol (120 mg/dl)-treated neural progenitors also gen-
erate daughter cells by symmetrical division (B, examples of cells in different stages of cytokinesis), to regenerate 
neurospheres over a period of 44 (E) and 72 (G) hours, under mitogenic conditions. However, despite being cultured under 
mitogenic conditions, ethanol-treated progenitors also exhibit asymmetric division to generate morphologically dissimilar 
daughter cells (C, examples of asymmetrical division, showing daughter cells in different stages of cytokinesis). Over the period 
of 44 to 72 hours, one daughter cell exhibits somatic mobility (e.g., F,H, cell marked by a *), while the second daughter cells 
remains stationary (e.g., F,H, cell marked by +). The motile daughter cell transiently exhibits long filamentous processes (F,*), 
though these processes retract over a period of 72 hours (H,*), in mitogenic medium.
*
+
*
+
Time 0 18 hours 44 hours 72 hours
Ethanol (120mg/dl)
Symmetric division
Asymmetric division
Control
*
+
A
B
C
D
E
F
G
       HPage 6 of 17
(page number not for citation purposes)
BMC Neuroscience 2005, 6:59 http://www.biomedcentral.com/1471-2202/6/59significant decrease in the numbers of cells expressing Sca-
1 (~23-fold), CD117/C-kit (~9-fold) and CD133/pro-
minin-1 (~19-fold) on their cell surface, after treatment
with ethanol at 120 mg/dl (p < 0.05, N = 9 samples per
stem cell antigen group). Increasing the dose of ethanol
did not lead to a further reduction in stem cell antigen
expression.
We wanted to examine the extent to which ethanol sup-
pression of cell-surface stem cell marker expression was a
generalized phenomenon that could be observed with
other, more selective, stem-cell markers. Therefore, in our
next experiment we examined the expression of the ATP-
binding multidrug transporter ABCG2, an integral mem-
brane protein that identifies stem cells in many tissues
including the nervous system [48], and is considered a
reliable marker for stem cells [49-52]. We examined the
cellular expression of ABCG2 by flow cytometry in neuro-
sphere cultures exposed to ethanol at the same dosages
and time period. Figure 7A shows that ethanol signifi-
cantly reduced the number of live cells that expressed
ABCG2 immunofluorescence after 4 days (p < 0.05).
These data suggest that ethanol does indeed suppress the
expression of a specific cell-surface stem cell marker in
neurosphere cultures.
In contrast to the above cell-surface markers, nestin is an
intermediate filament protein that is expressed by both
stem and progenitor cells within neurospheres ([45] and
Figure 1A), and levels decline in differentiated post-
mitotic neurons [53]. We hypothesized that if ethanol
suppressed the expression of cell-surface stem cell
markers, it would similarly suppress the expression of
mRNA for nestin. However, semi-quantitative RT-PCR
analysis (Figure 7B) showed that there was no change in
nestin mRNA expression (normalized to cyclophilin-A)
following ethanol exposure. These data suggest that while
ethanol may not decrease the overall size of the precursor
pool (the combined stem and blast pool, indicated by
constant nestin mRNA expression), it decreases the diver-
sity of stem cells within this pool (indicated by decreased
numbers of cells expressing Sca-1, c-kit, CD133 and
ABCG2).
Ethanol reduces telomerase reverse transcriptase (TERT) 
mRNA levels in neurosphere cultures
Telomerase reverse transcriptase (TERT) has been shown
by others to function as a neuroprotective factor in devel-
oping neurons. Therefore, we tested the hypothesis that
ethanol targets TERT transcription in progenitor neurob-
lasts. Reverse transcription PCR (Figure 8A, B) shows that
TERT mRNA levels were modestly but statistically signifi-
cantly increased (p < 0.05) at the low ethanol dosage (120
mg/ml). Conversely, high levels of ethanol (620 mg/dl)
produced a statistically significant decrease in TERT
Quantitative analysis of the effect of ethanol-pretreatment on the regenerative capacity of n ural progenito  cellsFigure 5
Quantitative analysis of the effect of ethanol-pretreatment on 
the regenerative capacity of neural progenitor cells. Neuro-
sphere cultures were treated with varying doses of ethanol 
for five days, then dissociated and cultured as individual pro-
genitor cells, in ethanol-free mitogenic medium. Ethanol pre-
treatment leads to a dose-related decline in the subsequent 
ability of neural progenitors to undergo cell division (mean 
number of dividing cells per well ± SEM) and generate clonal 
colonies of cells. Asterisks indicate statistical-significance, p < 
0.05.
Quantitative analysis of flow-cytometric data for stem-cell antigen expression in cortical pr genitorsFigure 6
Quantitative analysis of flow-cytometric data for stem-cell 
antigen expression in cortical progenitors. Progenitors 
express stem-cell antigens (control). After 4 days of treat-
ment, low doses of ethanol significantly reduced the propor-
tion of cells expressing Sca-1, CD117/C-kit and CD133. The 
high dose of ethanol did not further reduce stem-cell antigen 
expression. Asterisks indicate statistical-significance, p < 
0.05. Data were collected from at least 10,000 events/sam-
ple.
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BMC Neuroscience 2005, 6:59 http://www.biomedcentral.com/1471-2202/6/59mRNA levels. We hypothesized that the ethanol-induced
changes in TERT mRNA levels would lead to changes in
the activity of telomerase complex itself. However, quan-
titative measurements of telomerase activity indicate that
low and high doses of ethanol do not affect the activity of
the telomerase complex (Figure 8C). The cycle threshold
values in the low and high ethanol-treated groups were
identical, reflecting equal amounts of telomerase activity
in each sample. The increase in TERT transcription
following low doses of ethanol (120 mg/dl) was not fol-
lowed by a measurable increase in telomerase activity, an
unexpected observation in light of the marked induction
of DNA synthesis and cell-cycle progression illustrated in
Figure 2A, B. These results suggest that ethanol may
uncouple telomerase activation from neuroepithelial cell
proliferation.
Ethanol prevents subsequent differentiation of cells 
derived from neurosphere cultures
In the final set of experiments, we examined the effect of
ethanol on the subsequent differentiation potential of
cortical progenitor cells. We hypothesized that ethanol
induction of cell proliferation, would alter the ability of
cortical progenitors to differentiate into neurons. Rat neu-
rosphere cultures we maintained in control medium or
exposed to the low or moderate doses of ethanol (120 or
320 mg/dl) for 4 days. Following this period of ethanol
exposure, we dissociated neurospheres and cultured the
constituent cells at low density in the presence of 10 nM
retinoic acid. Neurosphere-derived cells were cultured at
low density so that individual cells would have a low
probability of contacting another cell. This protocol was
followed to reduce the impact of cell-cell interactions and
target-derived trophic support mechanisms on neuronal
differentiation. We selected retinoic acid as the differenti-
ation stimulus, since previous work in our laboratory
showed that retinoic acid is a strong trigger for cortical
neuroepithelial differentiation [54]. Overall, ethanol pre-
exposure led to a significant dose-related decline in the
number of first-order (p < 0.0001) and second-order (p <
0.003) branches that were induced following retinoic acid
exposure (Figure 9A). Naïve cells, and cells derived from
neurospheres pre-exposed to the low dose of ethanol (120
mg/dl) exhibited a strong differentiation phenotype in
response to retinoic acid (Figure 9B, C), including the
expression of second-order neurite branching. However,
(A) ABCG2 Transporter expression in cortical progenitors after ethanol treatmentFigure 7
(A) ABCG2 Transporter expression in cortical progenitors after ethanol treatment. Cultures w ere exposed to ethanol and 
live, immuno-labeled cells were processed for FACS analysis (see methods) with antibodies to surface ABCG2. Ethanol signifi-
cantly reduced the expression of ABCG2 (p < 0.05). Data were collected from 100,000 events/sample. (B) RT-PCR analysis for 
nestin in cortical progenitors treated with ethanol for 4 days. The levels of each transcript were unchanged by ethanol. Tran-
script levels were normalized to cyclophilin (data not shown).
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BMC Neuroscience 2005, 6:59 http://www.biomedcentral.com/1471-2202/6/59cells derived from neurospheres pre-exposed to 320 mg/dl
exhibited a marked reduction in neurite branching in
response to retinoic acid (Figure 9D).
Discussion
Our data show that ethanol did not induce appreciable
apoptosis in embryonic cortical-derived neurosphere
cultures. These data are somewhat surprising because the
activation of cell death mechanisms is intuitively consist-
ent with ethanol's adverse effects on brain development.
However, ethanol induction of cell death may be
differentiation stage-specific. For example, previous
research in our laboratory demonstrated that ethanol con-
centrations equal to those used in this study induced
apoptosis in more differentiated postnatal cortical [10],
and cerebellar explant cultures [11], perhaps because
tumor-suppressor genes like p53, and down-stream pro-
apoptotic genes like Bax are suppressed in proliferating
cortical cells and only induced during differentiation [54].
Clearly, more research is needed to identify genes and
mechanisms that confer apoptosis-resistance to precur-
sors, but not differentiated neuronal cells.
Ethanol promotes cell-cycle activity
Rather than killing cells, ethanol stimulated DNA synthe-
sis and promoted cell-cycle progression in cerebral corti-
cal precursors as indicated by the increase in the size
variation and number of neurospheres, induction of S-
phase, and increased progression through G2/M phases of
the cell cycle. On the other hand, ethanol induced asym-
metric division in progenitor cells and decreased the cell
surface expression of a number of stem cell markers, i.e.,
c-kit/CD117, Sca-1 (Ly6A/E), CD133/prominin-1 and the
ABCG2 transporter. In contrast to the induction of cell
cycle, asymmetric cell division and loss of stem cell anti-
gens are both indicative of neuroepithelial maturation.
These apparently antagonistic data are best explained
within the context of normal cerebral cortex development.
Neurogenesis in the developing cerebral cortex, occurs
within two distinct germinal zones, the earlier developing
ventricular zone, and the later developing subventricular
zone. Proliferation within the ventricular zone serves to
replenish stem and blast pools (by symmetrical division)
and to generate more mature, fate-restricted daughter
progeny (by asymmetrical division, [55]). The ethanol-
induced asymmetric division and loss of stem cell markers
supports the notion that ethanol induces maturation of
the stem cell pool. The daughter blast cells or 'proto-neu-
rons' that exit the ventricular zone, migrate in turn to the
subventricular zone where they may continue to prolifer-
ate and generate neurons, principally by symmetrical divi-
sion [55]. The increased proliferation that we observed in
ethanol-treated cultures may therefore reflect the expan-
sion of a 'subventricular-zone-like phenotype'. Recent evi-
dence suggests that the first blast cells that migrate out of
(A,B) TERT mRNA expression and telomerase activity in cortical-derived neuros heres treated with ethanol for 4 daysFigure 8
(A,B) TERT mRNA expression and telomerase activity in 
cortical-derived neurospheres treated with ethanol for 4 
days. (A), RT-PCR for the TERT transcript. (B), Quantifica-
tion of TERT levels in A, expressed as a ratio to cyclophilin. 
Low doses of ethanol modestly, but significantly, increased 
TERT transcript levels. However, high doses of ethanol 
decreased TERT mRNA expression. (C), TRAP assays 
revealed no differences in telomerase activity between 
treated and control groups. The cycle threshold value (Ct) 
indirectly measures activity; a lower Ct corresponds to 
higher telomerase activity. Inset table indicates Ct ± Standard 
Deviation (SD). Color code: Black, control; blue, 120 mg/dl; 
red, 620 mg/dl; pink, no-telomerase control. Asterisks indi-
cate statistical-significance, p < 0.05.
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cells are also precursors for mature neurons (for review,
see [56]). This view is consistent with our observations
that asymmetric division occasionally resulted in the
appearance of polarized cells with long (radial-like)
processes that fit morphological criteria for radial glia.
Further support for this 'two-zone' hypothesis of ethanol's
action comes from our observations that ethanol treat-
ment does ultimately deplete the regenerative capacity of
cortical neuroepithelial precursors. Cells derived from
ethanol-pretreated neurospheres exhibited a decreased
ability to form new colonies, implying that the loss of
stem cell markers does indeed mean that ethanol depletes
stem cells from the pool of immature precursors.
Overall, this interpretation of these data in terms of stem
cell maturation is also consistent with previously pub-
lished work from other laboratories using alternate labe-
ling indices, showing that ethanol decreases cell
proliferation within the ventricular zone, while increasing
cell proliferation within the more differentiated subven-
tricular zone [27,57,58]. Increased cell proliferation is a
requirement for differentiation in other tissues as well. For
example, in the hematopoietic system, the differentiation
of CD34+ stem cells into pro-erythroblasts is accompa-
nied by a significant increase in cell cycle. This induction
of cell cycle supports successive stages of blast maturation,
till the formation of the orthochromatophilic erythrob-
last, the immediate blast precursor to the differentiated
erythrocyte [26].
The consequences of enhanced proliferation on neural
differentiation remain to be determined. The diversity of
cellular subpopulations that contribute to the lamination
of the cortical plate is likely to be disrupted, leading to an
overabundance of some neuroblast populations at the
expense of others. Such population imbalances may be
one cause of phenomena like cellular heterotopias that
have been observed in brains of children with FAS [59],
and in animal models of FAS [60]. While in vitro models
suggest that migration defects contribute to the formation
of heterotopias [61], the role of aberrant ethanol-driven
expansion of specific progenitor pools in heterotopia for-
mation cannot be ruled out.
Ethanol limits cortical stem cell diversity in neurosphere 
cultures
Neurosphere cultures consist of a heterogeneous mixture
of multi-potent neuronal stem cells and daughter neurob-
lasts [47]. CD133/prominin-1 identifies stem cell groups
with multi-potent properties in the developing central
nervous system of humans and rodents [62-66]. Sca-1
(Ly6A/E) identifies hematopoietic cells with the potential
to form neurons, while CD117/C-kit [67-69] and the
ABCG2 multi drug-resistance transporter [48] are
expressed in stem cell precursors of the rodent central
nervous system. We demonstrate that populations of cor-
tical precursors do express these stem cell markers. Nestin
mRNA was also expressed in cultured cortical precursors,
but nestin mRNA levels did not change with ethanol
exposure, indicating that despite maturational pressure,
immature, possibly blast-type cells continue to persist in
ethanol-treated cultures. However nestin mRNA expres-
sion is not informative about the extent to which ethanol
affects the heterogeneity of stem cells in culture, because
nestin expression is a common phenotype of stem and
more differentiated blast cells. In contrast, ethanol
Pre-treatment with ethanol disrupts retinoic acid-mediated differentiationFigu  9
Pre-treatment with ethanol disrupts retinoic acid-mediated 
differentiation. Neurosphere cultures were exposed to a 
dose range of ethanol for 4 days, dissociated into a single cell 
suspension, plated and then differentiated with retinoic acid 
(A) Quantitative analysis of the mean number (± SEM) of pri-
mary and secondary branches per cell, formed in the pres-
ence of retinoic acid, as a function of ethanol pre-treatment 
dose. Asterisks indicate statistically significant differences 
from non-ethanol exposed, control cultures, * = p < 0.003; 
** = p < 0.0001. (B-E) Representative photomicrographs of 
branching patterns observed in the presence of retinoic acid, 
in control (B), low (C) and moderate doses (D,E) of etha-
nol. Arrows point to second-order branches, which are miss-
ing in cells derived from neurosphere cultures exposed to 
320 mg/dl ethanol. Scale bar, B-E, 25 uM
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cell-surface Sca-1, c-kit, CD133 and ABCG2. The absence
of an appreciable degree of apoptosis in ethanol-treated
cultures, suggests that ethanol influences the diversity of
the stem cell pool, rather than cell survival per se. In the
context of the previously noted requirement for cell cycle
induction as a component of stem cell to blast cell trans-
formation [26], it is interesting to note that the
suppression of the stem cell marker Sca-1 [70]) promotes
myoblast proliferation. Consequently, our observations
that ethanol induces cell cycle and decreases the expres-
sion of stem cell markers is mutually consistent with the
hypothesis that ethanol drives stem cell to blast cell trans-
formation in cortical neuroepithelial precursors.
The functions ascribed to the stem cell markers that we
utilized in this study are particularly relevant to the issue
of ethanol's impact on cell fate determination. For exam-
ple, CD133 and c-kit are important components of lipid
raft micro-domains [71,72], that sequester cell-signaling
machinery. In bone marrow, Stem Cell Factor/c-kit inter-
actions form a critical component of stromal-driven dif-
ferentiation of several hematopoietic lineages [73].
Therefore, changes in the composition of lipid rafts are
likely to result in significant alterations to signaling mech-
anisms that drive stem cell differentiation, and in the
brain, lead to aberrant development. Sca-1 is also a sign-
aling molecule, linked to the cell-surface by a phosphati-
dyl-inositol anchor, and is important for stimulating
hematopoietic stem cell renewal [74]. Sca-1 expression is
suppressed in hematopoietic stem cells, during the proc-
ess of lymphocyte differentiation [75]. While Sca-1 may
well exhibit different developmental-stage associated
kinetics in the neuroepithelium, ethanol-dependent
depletion of Sca-1 in the neuroepithelium may similarly
drive precursor maturation and prevent the renewal of a
stem cell pool. Interestingly, both Sca-1 [70] and CD117/
c-kit [76,77] share the Src-like tyrosine kinase Fyn as a
common signaling intermediary, suggesting that the two
cell-surface molecules mediate common functions during
development. Fyn in turn, mediates ethanol-sensitivity
and dependence in the adult animal, and a Fyn polymor-
phism is predictive of alcohol dependence in human pop-
ulations [78-80], further suggesting that ethanol's effects
in the developing and adult brain are likely to be medi-
ated by common mechanisms. Finally, ethanol suppres-
sion of the expression of multi-drug resistance
transporters like ABCG2 is also likely to be clinically
significant. Multi-drug resistance transporters are thought
to protect stem cells from damage by non-selectively
extruding a wide variety of cytotoxic compounds [52].
Ethanol exposure, by suppressing ABCG2 expression, may
decrease the survivability of neural stem cells in the face of
subsequent toxic insults, including perhaps, subsequent
episodes of ethanol exposure.
Ethanol's effect on Telomerase activity and TERT 
transcription
Rapidly dividing tissues are susceptible to errors in DNA
synthesis that can lead to DNA damage, chromosomal
instability and cell death. The telomerase complex main-
tains chromosomal ends, and consequently ensures chro-
mosome stability during DNA synthesis (reviewed in [81-
83]). Telomerase activity is robust during embryogenesis
[84] and is particularly elevated in the proliferating neu-
roepithelium. Though activity is decreased following cel-
lular differentiation, the catalytic component of
telomerase (TERT) continues to be expressed widely in
post-mitotic neurons where it appears to function as a
neuroprotective factor [40,41,85]. The lower dose of
ethanol (120 mg/dl) resulted in increased TERT mRNA
levels, perhaps as a compensatory protective response. In
contrast, the suppression of TERT mRNA expression at
high doses (620 mg/dl) is inconsistent with the observed
increase in cell cycle progression at that dose. Interest-
ingly, TERT physically associates with the anti-apoptotic
kinase AKT [86], and a reduction in TERT expression levels
has the potential to render dividing cortical precursors
susceptible to future apoptotic stimuli, (for example, see
[41,87,88]), even if ethanol itself does not induce
apoptosis.
Because we observed that ethanol increased cell cycle
activity in neurosphere cultures, we hypothesized that
ethanol would also increase telomerase activity.
Surprisingly, ethanol had no effect on telomerase activity.
The lack of coordination between telomerase activity and
changes in cell cycle activity suggests that DNA synthesis
is likely to be incomplete in telomeric regions, increasing
genomic instability in proliferating, ethanol-exposed neu-
roblasts. Recent research indicates that the prenatal rodent
neuroepithelium normally exhibits a significant degree of
genetic mosaicism in which 33% of all cortical precursors
display some degree of chromosomal aneuploidy [89]
and loss of heterozygosity [90]. It is surprising that the
developing neuroepithelium tolerates such a significant
degree of genetic instability without negative sequellae.
However, given a high tolerance for mosaicism, any
increases in genetic instability among ethanol-exposed
cells of the neuroepithelium may not result in apoptosis,
but in altered patterns of gene expression due to mecha-
nisms like gene shedding [90], consequently altering neu-
ral differentiation. An intriguing possibility, supported by
the discrepancy between telomerase and cell cycle data, is
that the accumulation of progenitors with greater than G0
DNA content in ethanol-treated cultures represents
increased aneuploidy rather than increased progression
through cell cycle per se.Page 11 of 17
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neuronal differentiation
The loss of stem cell markers, and evidence for increased
cell division led us to hypothesize that ethanol exposure
would promote the further maturation of the cortical stem
and blast cells. However, contrary to our hypothesis, eth-
anol pre-treated neural progenitor cells were refractory to
retinoic acid stimulation. Though retinoic acid is a potent
stimulator of neuronal differentiation [54], it appears to
have growth-stimulatory effects in part, by stimulating
neurotrophic signaling via factors like glial-derived neuro-
trophic factor and neurotrophin-3 [91]. Since ethanol has
been previously shown to interfere with growth factor sig-
naling mechanisms in a variety of neural differentiation
models [11,14-17,92], it is likely that ethanol disrupts
growth factor signaling to interfere with the response to
retinoic acid as well. The developmental consequences of
delays in neuronal differentiation are likely to be pro-
found. Even if the effect of ethanol is transient, the inside-
out lamination of the cortical plate is likely to be signifi-
cantly disrupted, because later-generated neural precur-
sors do not appear to be able to populate earlier-
developing cortical plate laminae, after the critical period
for the generation of that specific lamina has been passed
[93].
Conclusion
In toto, our data support the hypothesis that the elimina-
tion of neural stem cell diversity contributes to the etiol-
ogy of prenatal brain damage caused by maternal ethanol
consumption. Rather than inducing apoptosis, ethanol
stimulates cell-cycle activity and eliminates stem cell anti-
gen expression. It is likely therefore, that ethanol drives
the stem cell to blast cell transformation, ultimately
depleting the reserve regenerative capacity of cerebral cor-
tical neuroepithelium. Secondly, the uncoupling of tel-
omerase activity from cell-cycle induction suggests that
ethanol exposure may hasten telomere decay and cellular
senescence, rendering maturing neuroblasts susceptible to
genetic damage as they proceed through cycles of matura-
tion-driven proliferation. Finally, if the ventricular and
subventricular zones are indeed 'proto-maps' of the
mature cortical plate [28], restrictions in the diversity of
the stem cell pool are likely to translate into loss of diver-
sity of neuronal and glial phenotypes that populate the
mature cortical plate. While the developmental conse-
quences of perturbing the cortical stem cell pool have not
been adequately assessed in experimental systems of eth-
anol-induced brain damage, one likely sequel to such
perturbations is a permanent transformation in the phe-
notypic composition of the neural network of the cerebral
cortex.
Methods
Isolation of embryonic neural precursors
The University Laboratory Animal Care Committee
approved all animal procedures. Timed-pregnant
Sprague-Dawley rats (gestational day [GD] 13) were pur-
chased from Harlan, Houston, Texas, and maintained in
the animal housing facility at Texas A&M University Sys-
tem Health Sciences Center, College of Medicine for two
days until the pregnancy matured to GD15. At GD 15,
pregnant females were anesthetized with ketamine (0.09
mg/gram)/xylazine (0.106 mg/gram) by intraperitoneal
injection. Under aseptic conditions, the gravid uterus was
delivered through a midline transverse abdominal inci-
sion. The gravid uterus was rinsed in chilled PBS contain-
ing 1% penicillin/streptomycin. Eight to ten fetuses were
isolated and rinsed three times in chilled PBS. Anesthesia
was achieved by placing fetuses in ice-cold Gey's Balanced
Salt Solution. Fetuses were rapidly decapitated, and whole
brains were removed and placed in chilled Gey's Balanced
Salt Solution supplemented with glucose and magnesium
chloride. Brains remained suspended in this solution
throughout the remainder of the microdissection proce-
dure. Meningeal tissue was removed, regions of the rat
fetal brain corresponding to the structural precursor of the
neocortex were isolated, and care was taken to exclude the
structural precursors to the striatum and hippocampus.
Individual cortical fragments were collected in sterile 15
ml conical tubes and gently triturated in trypsin/EDTA.
Trypsin was inactivated with DMEM containing 10% fetal
bovine serum. The cell suspension was centrifuged for 5
minutes at 18°C, 1000 rpm (300 × g). Cell pellets were
resuspended in chilled PBS containing 0.5% BSA,
Fraction-V, (#1526037, Invitrogen) and 2.0 mM EDTA.
Total cell counts were determined using a hemocytometer
Cell culture
Neurosphere cultures were established from acutely disso-
ciated cortices (described above). Precursor cultures were
established at an initial density of 106 cells in T-25 flasks
containing 5–6 ml of serum-free mitogenic media
(DMEM/F12 (#11330-032 Invitrogen), 20 ng/ml bFGF
(#13256-029 Invitrogen), 20 ng/ml hEGF (#53003-018
Invitrogen), ITS-X supplement (#51500-056 Invitrogen),
0.85 Units/ml heparin (#15077-019 Invitrogen), and 20
nM progesterone (#P6149 Sigma)). Cultures were incu-
bated at 37°C, 5% CO2 in a humidified environment for
48–72 hours before the commencement of ethanol treat-
ments to allow for stabilization of culture and for the gen-
eration of small neurospheres, a sign of precursor
expansion. For some experiments, following ethanol
treatment, neurosphere cultures were dissociated and dif-
ferentiated for 4.5 days in the presence of 10 nM retinoic
acid (in DMEM/F12 and 1%N2 supplement).Page 12 of 17
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Cultures were assigned to three treatment groups: (I) a
control group containing no ethanol; (II) a low dose
group containing 120 mg/dl (26.07 mM); (III) a high
dose group containing 620 mg/dl (134.78 mM, prepared
from 95% ethanol, molecular biology grade-Sigma). For
some experiments, an intermediate, dose of ethanol, 320
mg/dl (69.56 mM) was used in place of the high dose. Gas
chromatographic analyses indicated that the low and high
doses resulted in ethanol levels of 97–106 mg/dl (21.09
mM–23.04 mM) and 367–557 mg/dl (79.35 mM–121.09
mM) respectively, while the moderate dose of ethanol
resulted in measured levels between 182–227 mg/dl
(39.57 mM–49.35 mM). These concentrations are within
the range that has been previously observed in chronic
alcoholics [94,95]. Doses of 150 mg/dl and 200 mg/dl
have been used previously in cell culture models of
chronic ethanol exposure [96,97]. The ethanol concentra-
tions used in this study are expected to reflect the levels in
the fetus during prenatal exposure, as it has been shown
in rodent models that maternal blood alcohol levels pro-
duce equivalent concentrations in the fetus [98]. The eth-
anol treatment lasted 4 days. Ethanol containing media
was replaced daily throughout the duration of the treat-
ment period.
Labeling for stem cell surface antigen expression
Neurosphere cultures were dissociated in Accumax solu-
tion (Innovative Cell Technologies) by gentle trituration
through a fire polished pipette. Precursors were labeled
with phycoerythrin-conjugated antibodies to Sca-1/Ly6A/
E (1 ug, Caltag Labs, MM4104), CD117/c-kit (1 ug, BD
Pharmingen, 555714), CD133/prominin-1 (0.55 ug,
Miltenyi Biotec, AC141), BCRP1 (ABCG2)-FITC (1 ug,
Chemicon International MAB4155F) or isotype-matched
IgG. 106 live cells were incubated separately with each of
the above antibodies for 10 minutes at 4°C and immedi-
ately analyzed by flow cytometry. In each group, an equal
amount of unlabeled IgG isotype-matched antibody was
added to the labeling solution to serve as a blocking rea-
gent for potential Fc-Receptor sites on the cell surface.
Between 10,000 and 100,000 cells were counted in each
sample. Staining levels from cells labeled with phyco-
erythrin-conjugated IgG isotype-matched antibodies
served as a measure of background fluorescence. This
background was subtracted from all groups labeled with
stem cell antigen markers and flow cytometric data were
collected for this population of cells. The proportion of
labeled cells was expressed as the percentage of total cells
gated.
Propidium iodide staining for DNA content
Neurosphere cultures were dissociated in Accumax solu-
tion (Innovative Cell Technologies) as mentioned above.
Dissociated cells were collected by brief centrifugation at
1000 rpm, 18°C and resuspended in cold PBS. An equal
volume of 2% phosphate-buffered paraformaldehyde was
added to yield a final concentration of 1% paraformalde-
hyde. Cells were fixed for 45 minutes at 4°C. Fixed cells
were washed twice in PBS and resuspended in PBS con-
taining 0.5 mM EDTA, 0.1% Triton X-100, 0.05 mg/ml
RNAse A (#R4642 Sigma). Cells were incubated at 37°C
for 30 minutes to allow for RNA degradation. Propidium
iodide (#1348639 Roche) was added to the solution at a
final dilution of 1:50 and incubated for at least 30 min-
utes at 4°C. At least 10,000 cells were analyzed by flow
cytometry.
Flow cytometry
Cell cycle analysis and measurements of stem cell antigen
levels were conducted on a FACS Calibur Flow Cytometer
(Beckton Dickinson). Excitation wavelength was set at
488 nm (Argon laser) and emission spectra for phyco-
erythrin and propidium iodide were 575 nm and 630 nm,
respectively. Cell-cycle histograms were generated using
Cell Quest software for Macintosh.
Immuno-fluorescence analysis
Neurosphere cultures were assayed for the expression of
the neuroepithelial marker Nestin, and neuronal marker
NeuN (neuronal nuclear antigen), according to previously
published protocols [54]. After 3.5–4 days, media was
removed and cultures were washed in PBS, fixed in 1%
phosphate-buffered paraformaldehyde for 45 minutes at
room temperature. Cultures were rinsed twice with PBS
and once with TBS, followed by incubation in blocking
solution (2% normal serum, 0.1% BSA, 0.2% triton x-
100, in TBS) for 1 hour at room temperature. Antibodies
(all from Chemicon) against nestin 1:100 (MAB3353)
and NeuN 1:100 (MAB377), were diluted in staining solu-
tion (TBS 0.1% BSA), and incubated with cells overnight
at 4°C. Following three washes in TBS, cells were labeled
with rat-adsorbed, biotinylated secondary horse anti-
mouse antibodies (1:250) (Vector Laboratories) in TBS
according to manufacturers instructions, and antibody
binding was visualized with by conjugation with avidin-
rhodamine 1:250 (Vector Laboratories). Cells were
mounted in Fluorescence Mounting Media containing
DAPI (Vector Laboratories).
RNA extraction and cDNA synthesis
RNA was extracted using the Trizol reagent in accordance
with the manufacturer's instructions (Invitrogen). RNA
was purified with the SV Total RNA Isolation System
(#Z3100 Promega). 2.5 micrograms of total RNA was
used to synthesize cDNA using the Superscript III First-
Strand Synthesis System for RT-PCR (Invitrogen #18080-
051) and random hexamers according to the manufac-
turer's protocol.Page 13 of 17
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PCR was performed by conventional thermocycling meth-
ods. 2 uls of cDNA mixture from above was combined
with the primers (200 nM each) and PCR Supermix
(#10572-014, Invitrogen) in a total volume of 50 ul.
Primers for TERT were those used in (Holzmann et al.,
2003). PCR products were resolved by agarose gel electro-
phoresis and visualized by ethidium bromide staining.
The cyclophilin-A (Peptidyl-prolyl cis-trans isomerase A)
gene served as an internal control measure [99,100]. For-
ward and reverse primer sequences are as indicated in
Table 1.
Measurement of telomerase activity by TRAP Assay
Telomerase is a reverse transcriptase ribonucleoprotein
complex that catalyzes the addition of six base pair repeats
to telomeric ends [101-103]. The PCR-based Telomeric
Repeat Amplification Protocol (TRAP), to measure telom-
erase activity in biological samples, was adapted from
[38], as described in [104], based on SYBR-Green I
fluorescence and real-time PCR. PCR reactions were per-
formed with SYBR Green JumpStart TaqReady Mix (Sigma
#S4438). Cell pellets were homogenized in 200 uL of cold
lysis buffer and chilled on ice for 30 minutes, then re-sed-
imented by centrifugation at 16,000 × g for 20 minutes at
4°C, then lysed in CHAPS lysis buffer [85]. Lysates were
quantified for total protein content and diluted to a work-
ing concentration of 100 ng/ul and stored at -80°C until
use. The TS and ACX primers used for both the telomerase
elongation and the amplification of telomerase elonga-
tion products are as described in [105]. The following
components were mixed in a 25 ul volume and analyzed
for telomerase activity; 13 ul SYBR Jumpstart Mix, 0.1 ug
(1 ul) TS primer, 0.05 ug (1 ul) ACX primer (for primer
sequence, see Table 1), 0.2 ul T4 Gene 32 Protein (1 unit,
Roche 972983), 1 ul extract (100–500 ng) and water to 25
ul final volume. SYBR Green fluorescence intensity was
quantified during the 60°C annealing/elongation step
and expressed graphically as a function of cycle number.
Cycle threshold values (Ct) are an indirect measurement
of telomerase activity and represent the cycle number at
which the generated product reaches a preset threshold
level. Thresholds were set at 10 standard deviations above
background fluorescence.
Data analysis
TERT and nestin mRNA levels were quantified by densito-
metric measurement, and were expressed as a ratio of
cyclophilin-A mRNA expression (Molecular Analyst for
Windows, BioRad). For TRAP assays, Sybr-Green fluores-
cence intensities were plotted against cycle number, and
cycle threshold (ct) determined. Neurosphere number
and size were computed using a Java version of NIH image
(ImageJ, V1.32j (NIH)). Data were analyzed using a
standard statistical package, SPSS for Windows (Version
11). Analysis of Variance (ANOVA) and the Fischer's Least
Significant Difference post-hoc test were used to identify
statistically significant differences between groups. Alter-
natively, Pearson's correlations, and two-tailed tests of sig-
nificance were computed to determine relationships
between ethanol dose and response. Statistical signifi-
cance was set at p < 0.05.
List of abbreviations
CD117 C-kit
CD133 prominin-1
ABCG2 ATP-binding cassette, sub-family G (WHITE),
member 2; member of the ATP-dependent multi-drug
resistance transporter family; aka. BCRP1
FAS Fetal Alcohol Syndrome
NeuN Neuronal nuclear antigen
Sca-1 Stem Cell Antigen-1 or Ly6A/E
TERT Telomerase reverse transcriptase subunit
Table 1: List of PCR primers
Primer Name Sequence Product Size Accession #/Reference
TS primer 5'-ATTCCGTCGAGCAGAGTT-3' [105]
ACX primer 5'-GCGCGG [CTTACC]3CTAACC-3'
R-Tert_Forward GGTCTTCCGCACGTTGGTTG 349bp [106]
R-Tert_Reverse CAGCAGGTAGAGCGCACAGT
Rat_Nestin_Forward TGCAGCCACTGAGGTATCTG 1061bp Acc#: M34384
Rat_Nestin_Reverse AGTTCCCACTCCTGTGGTTG
Cyclophilin A_Forward TGGTCAACCCCACCGTGTTCTTCG 372bp Acc#: M19533
Cyclophilin A_Reverse TGCCATCCAGCCACTCAGTCTTGGPage 14 of 17
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